Clinical Trials Directory

Trials / Completed

CompletedNCT04497090

Adaptive Non-invasive Ventilation to Abolish Tidal Flow Limitation

Non-invasive Ventilation With Automatic Expiratory Positive Airway Pressure Titration to Abolish Tidal Expiratory Flow Limitation in COPD Patients With Chronic Hypercapnia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Politecnico di Milano · Academic / Other
Sex
All
Age
18 Years – 84 Years
Healthy volunteers
Not accepted

Summary

This study aimed to evaluate the effects of a novel automatic non-invasive ventilation (NIV) mode that continuously adjusts expiratory positive airway pressure (EPAP) to the lowest value that abolishes tidal expiratory flow limitation. The investigators conducted a prospective, randomized, cross-over study on stable chronic obstructive pulmonary disease (COPD) patients. Patients were studied in the hospital during two non-consecutive nights while using either fixed or adaptive EPAP. The primary outcome was the transcutaneous partial pressure of carbon dioxide. Secondary outcomes were: oxygen saturation, breathing pattern, oscillatory mechanics, patient-ventilation asynchronies, sleep quality and sleep-related respiratory events.

Detailed description

Study design: prospective, randomized, cross-over study. Study population: moderate to severe COPD patients, long-term users of nocturnal non-invasive ventilation for chronic hypercapnic respiratory failure. Inclusion criteria: age\<85 years; presence of tidal expiratory flow limitation in the supine position at an expiratory positive airway pressure of 4 cmH2O. Exclusion criteria: COPD exacerbation within the past two months; acute illness; clinical instability. Study protocol: Patients were studied in the hospital over 2 non-consecutive nights while using either fixed or automatic EPAP. Ventilation strategy: pressure-controlled NIV was delivered using a non-commercial version of BiPAP Synchrony Ventilator (Philips-Respironics) via an unvented facial mask (AMARA, Philips-Respironics). The ventilator evaluated the presence of tidal expiratory flow limitation by the forced oscillation technique. In the automatic-EPAP mode, the ventilator continuously adjusted EPAP to the minimum level able to abolish tidal expiratory flow limitation, with a minimum EPAP of 4 cmH2O and keeping the pressure support constant. Measurements: During each study night, the investigators recorded transcutaneous partial pressure of carbon dioxide and oxygen saturation (TOSCA, Radiometer) continuously. Airway opening pressure, flow and volume tracings were exported from the ventilator. Full laboratory polysomnography (Alice5, Philips-Respironics) was performed according to the American Academy of Sleep Medicine recommendations. Data analysis: the investigators compared parameters from the two nights using Wilcoxon signed-rank test. P-values \<0.05 were considered statistically significant.

Conditions

Interventions

TypeNameDescription
DEVICEfixed-EPAPIn the fixed-EPAP mode, the device kept EPAP fixed at the prescribed value
DEVICEauto-EPAPIn the Auto-EPAP mode, the device automatically adjusted EPAP to the minimum level able to abolish tidal expiratory flow limitation.

Timeline

Start date
2014-10-23
Primary completion
2018-05-15
Completion
2018-05-15
First posted
2020-08-04
Last updated
2020-08-04

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04497090. Inclusion in this directory is not an endorsement.